Literature DB >> 19795815

Enhanced HTS hit selection via a local hit rate analysis.

Bruce A Posner1, Hualin Xi, James E J Mills.   

Abstract

The postprocessing of high-throughput screening (HTS) results is complicated by the occurrence of false positives (inactive compounds misidentified as active by the primary screen) and false negatives (active compounds misidentified as inactive by the primary screen). An activity cutoff is frequently used to select "active" compounds from HTS data; however, this approach is insensitive to both false positives and false negatives. An alternative method that can minimize the occurrence of these artifacts will increase the efficiency of hit selection and therefore lead discovery. In this work, rather than merely using the activity of a given compound, we look at the presence and absence of activity among all compounds in its "chemical space neighborhood" to give a degree of confidence in its activity. We demonstrate that this local hit rate (LHR) analysis method outperforms hit selection based on ranking by primary screen activity values across ten diverse high throughput screens, spanning both cell-based and biochemical assay formats of varying biology and robustness. On average, the local hit rate analysis method was approximately 2.3-fold and approximately 1.3-fold more effective in identifying active compounds and active chemical series, respectively, than selection based on primary activity alone. Moreover, when applied to finding false negatives, this method was 2.3-fold better than ranking by primary activity alone. In most cases, novel hit series were identified that would have otherwise been missed. Additional uses of and observations regarding this HTS analysis approach are also discussed.

Mesh:

Year:  2009        PMID: 19795815     DOI: 10.1021/ci900113d

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  16 in total

1.  Analysis of high-throughput screening assays using cluster enrichment.

Authors:  Minya Pu; Tomoko Hayashi; Howard Cottam; Joseph Mulvaney; Michelle Arkin; Maripat Corr; Dennis Carson; Karen Messer
Journal:  Stat Med       Date:  2012-07-05       Impact factor: 2.373

2.  An economic framework to prioritize confirmatory tests after a high-throughput screen.

Authors:  S Joshua Swamidass; Joshua A Bittker; Nicole E Bodycombe; Sean P Ryder; Paul A Clemons
Journal:  J Biomol Screen       Date:  2010-06-14

3.  Enhancing the rate of scaffold discovery with diversity-oriented prioritization.

Authors:  S Joshua Swamidass; Bradley T Calhoun; Joshua A Bittker; Nicole E Bodycombe; Paul A Clemons
Journal:  Bioinformatics       Date:  2011-06-17       Impact factor: 6.937

Review 4.  No time to lose--high throughput screening to assess nanomaterial safety.

Authors:  R Damoiseaux; S George; M Li; S Pokhrel; Z Ji; B France; T Xia; E Suarez; R Rallo; L Mädler; Y Cohen; E M V Hoek; A Nel
Journal:  Nanoscale       Date:  2011-02-07       Impact factor: 7.790

5.  Plate-based diversity subset screening: an efficient paradigm for high throughput screening of a large screening file.

Authors:  Andrew S Bell; Joseph Bradley; Jeremy R Everett; Michelle Knight; Jens Loesel; John Mathias; David McLoughlin; James Mills; Robert E Sharp; Christine Williams; Terence P Wood
Journal:  Mol Divers       Date:  2013-04-05       Impact factor: 2.943

6.  Managing missing measurements in small-molecule screens.

Authors:  Michael R Browning; Bradley T Calhoun; S Joshua Swamidass
Journal:  J Comput Aided Mol Des       Date:  2013-04-13       Impact factor: 3.686

Review 7.  Automating drug discovery.

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2017-12-15       Impact factor: 84.694

8.  Utility-aware screening with clique-oriented prioritization.

Authors:  S Joshua Swamidass; Bradley T Calhoun; Joshua A Bittker; Nicole E Bodycombe; Paul A Clemons
Journal:  J Chem Inf Model       Date:  2011-12-20       Impact factor: 4.956

9.  SCISSORS: practical considerations.

Authors:  Steven M Kearnes; Imran S Haque; Vijay S Pande
Journal:  J Chem Inf Model       Date:  2013-12-16       Impact factor: 4.956

10.  Bigger data, collaborative tools and the future of predictive drug discovery.

Authors:  Sean Ekins; Alex M Clark; S Joshua Swamidass; Nadia Litterman; Antony J Williams
Journal:  J Comput Aided Mol Des       Date:  2014-06-19       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.